JP2002537422A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002537422A5 JP2002537422A5 JP2000599794A JP2000599794A JP2002537422A5 JP 2002537422 A5 JP2002537422 A5 JP 2002537422A5 JP 2000599794 A JP2000599794 A JP 2000599794A JP 2000599794 A JP2000599794 A JP 2000599794A JP 2002537422 A5 JP2002537422 A5 JP 2002537422A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- porous polymer
- radical
- hydrogen
- polymerizable component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000642 polymer Polymers 0.000 description 18
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 230000000379 polymerizing Effects 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- -1 C 1 -C 4 - alkyl Chemical group 0.000 description 1
- 210000004087 Cornea Anatomy 0.000 description 1
- 229920002521 Macromolecule Polymers 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- INQDDHNZXOAFFD-UHFFFAOYSA-N triethylene glycol diacrylate Substances C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Description
【特許請求の範囲】
【請求項1】
(i)式(1)で示されるフリーラジカル重合性不飽和モノマーを含む重合性成分:
Q−X−A (1)
〔式中、Qは、式(2):
【化1】
で示されるラジカルであり、
Q1は、式(3a)又は(3b):
【化2】
で示されるラジカルであり、
(alk)は、直鎖状又は分岐状のC2−C12−アルキレンであり、
(alk′)は、直鎖状又は分岐状のC1−C12−アルキレンであり、
Rは、更に置換されていてもよい2〜24個の炭素原子を有するオレフィン性不飽和の共重合性ラジカルであり、
s及びtのそれぞれは、他方とは独立に、0又は1の数であり、
Xは、基:−O−、−S−又は−NR1−であり、R1は、水素、C1−C4−アルキル又はラジカルAであり、そして
Aは、式(4):
−〔(CH2)a−(Y)z−(CHF)b−(CF2)c〕−R2 (4)
(式中、R2は、水素又はフッ素であり、Yは、基:−N(R3)SO2−、−OSO2−、−OC(O)−又は−N(R3)C(O)−であり、R3は、水素又はC1−C4−アルキルであり、zは、0又は1の整数であり、aは、1〜15の整数であり、bは、0〜6の整数であり、そしてcは、1〜20の整数である)で示されるラジカルであるか、あるいは
Aは、部分的又は全体的にフッ素化されているC4−C8−シクロアルキルである〕、
並びに必要に応じて
(ii)コモノマー及び/又は
(iii)架橋剤
を重合することにより得られる多孔性ポリマーであって、
水で完全に膨潤すると、多孔性促進条件を除く従来条件下で重合される同じポリマーよりも高い含水量を有し、個々の孔の平均孔径が少なくとも10 nmである多孔性ポリマー。
【請求項2】
多孔性が、10000ダルトンまで、および10000ダルトンを超えるポリマー重量のタンパク質および他の生物学的高分子の流入を許容するのに充分であるが、角膜アンレーの光軸領域への細胞及び組織侵入を許容するのには充分でなく、
完全に膨潤すると、5−60 wt%の含水量を有する、
請求項1記載の多孔性ポリマー。
【請求項3】
Qが、式(2)〔ここで、sが、0であり、Q1が、上記式(3a)のラジカルであり、tが、0であり、そしてRが、式(5)で示されるラジカルである:
【化3】
(式中、lは、0の数であり、R4は、水素、C1−C4−アルキル又はハロゲンであり、そしてR5及びR6のそれぞれは、他方とは独立に、水素、C1−C4−アルキル、フェニル、カルボキシ又はハロゲンである)〕である、請求項1記載の多孔性ポリマー。
【請求項4】
Qが、下記式:
【化4】
で示されるラジカルである、請求項1〜3のいずれか1項記載の多孔性ポリマー。
【請求項5】
Xが、−O−、−NH−又は−N(C1−C2−アルキル)−である、請求項1〜4のいずれか1項記載の多孔性ポリマー。
【請求項6】
Aが、式(4)(ここで、R2は、水素又はフッ素であり、zは、0であり、aは、1〜4であり、bは、0〜4であり、そしてcは、1〜10である)のラジカルである、請求項1〜5のいずれか1項記載の多孔性ポリマー。
【請求項7】
Aが、式(4a):
−(CH2)a−(CF2)c−R2 (4a)
で示されるラジカルであり、R2は、水素又はフッ素であり、aは、1又は2の整数であり、そしてcは、1〜10の整数である、請求項1〜6のいずれか1項記載の多孔性ポリマー。
【請求項8】
重合性成分が、式(1)〔ここで、Qは、下記式:
【化5】
で示されるラジカルであり、Xは、−O−、−NH−又は−N(C1−C2−アルキル)−であり、そしてAは、式(4a):
−(CH2)a−(CF2)c−R2 (4a)
(式中、R2は、水素又はフッ素であり、aは、1又は2の整数であり、そしてcは、1〜10の整数である)で示されるラジカルである〕のモノマーを含む、請求項1記載の多孔性ポリマー。
【請求項9】
重合性成分が、式(1)の1種又は異なる2種以上のモノマーからなる、請求項1〜8のいずれか1項記載の多孔性ポリマー。
【請求項10】
重合性成分が、式(1)の1種又は異なる2種以上のモノマー及び架橋剤からなる、請求項1〜8のいずれか1項記載の多孔性ポリマー。
【請求項11】
架橋剤が、モノ−、ジ−、トリ−若しくはテトラエチレングリコールジアクリラート若しくはジメタクリラート又は式(6):
H2C=CR8-C(O)O-H2C-(CF2)1-10-CH2-O(O)C-CR8=CH2 (6)
〔式中、R8は、水素又はメチルである〕で示されるフッ素化化合物である、請求項10記載の多孔性ポリマー。
【請求項12】
重合性成分が、式(1)の1種又は異なる2種以上のモノマー、1種又は異なる2種以上の親水性コモノマー及び架橋剤からなる、請求項1〜8のいずれか1項記載の多孔性ポリマー。
【請求項13】
a)重合性成分及び有機溶媒を含む混合物を形成する工程(ここで、重合性成分は、請求項1記載の式(1)のフリーラジカル重合性不飽和モノマー、並びに必要に応じて更に別のコモノマー及び/又は架橋剤を含む);
b)該混合物を重合する工程(ここで、該混合物の重合直後に、少なくとも実質的な比率の該有機溶媒が、離散相の形にあり、そして該離散有機溶媒相が、混合物全体に相互貫通ネットワークを形成するか、又は混合物全体に分散される);並びに
c)離散有機溶媒相を除去する工程
を含む、請求項1記載の多孔性ポリマーの製造方法。
【請求項14】
有機溶媒が、C2−C8−アルコールである、請求項13記載の方法。
【請求項15】
請求項1〜12のいずれか1項記載の多孔性ポリマーを含む成形品。
【請求項16】
生物医学的装置、特に眼科用装置である、請求項15記載の成形品。
【請求項17】
医用インプラントである、請求項15記載の成形品。
【請求項18】
眼用プロテーゼ、特に角膜インプラントである、請求項15記載の成形品。
【請求項19】
創傷治癒包帯である、請求項15記載の成形品。
【請求項20】
細胞増殖材料としての、請求項1記載の重合性成分を重合することにより得られる無孔性又は多孔性ポリマーの使用。
【請求項21】
生物医学的又は生体材料の装置又は応用のための細胞増殖支持性コーティングとしての、請求項1記載の重合性成分を重合することにより得られる無孔性又は多孔性ポリマーの使用。
【請求項22】
移植可能な眼内レンズ又は人工角膜の製造のための、請求項1記載の重合性成分を重合することにより得られる無孔性又は多孔性ポリマーの使用。
[Claims]
(1)
(I) a polymerizable component containing a free radical polymerizable unsaturated monomer represented by the formula (1):
QXA (1)
[Wherein Q is the formula (2):
Embedded image
Is a radical represented by
Q 1 is the formula (3a) or (3b):
Embedded image
Is a radical represented by
(Alk) is a linear or branched C 2 -C 12 -alkylene;
(Alk ′) is a linear or branched C 1 -C 12 -alkylene;
R is an olefinically unsaturated copolymerizable radical having 2 to 24 carbon atoms which may be further substituted;
each of s and t is, independently of the other, a number 0 or 1;
X is a group: —O—, —S— or —NR 1 —, R 1 is hydrogen, C 1 -C 4 -alkyl or a radical A, and A is of the formula (4):
-[(CH 2 ) a- (Y) z- (CHF) b- (CF 2 ) c ] -R 2 (4)
(Wherein R 2 is hydrogen or fluorine and Y is a group: —N (R 3 ) SO 2 —, —OSO 2 —, —OC (O) — or —N (R 3 ) C (O )-, R 3 is hydrogen or C 1 -C 4 -alkyl, z is an integer of 0 or 1, a is an integer of 1 to 15, and b is 0 to 6 Is an integer and c is an integer from 1 to 20), or A is C 4 -C 8 -cycloalkyl which is partially or fully fluorinated. ,
And optionally (ii) a comonomer and / or (iii) a porous polymer obtained by polymerizing a cross-linking agent,
When fully swollen with water, have a high water content than the same polymer polymerized in conventional conditions except porosity promoting conditions, porous polymer average pore size of individual pores is at least 10 nm.
(2)
The porosity is sufficient to allow the influx of proteins and other biological macromolecules up to and over 10,000 Daltons, but does not allow cells and tissues to penetrate the optical axis region of the corneal onlay. Not enough to tolerate,
When fully swollen, it has a water content of 5-60 wt%,
The porous polymer according to claim 1.
(3)
Q is the formula (2) [where s is 0, Q 1 is a radical of the above formula (3a), t is 0, and R is represented by the formula (5) Is a radical:
Embedded image
Wherein 1 is a number of 0, R 4 is hydrogen, C 1 -C 4 -alkyl or halogen, and each of R 5 and R 6 independently of the other is hydrogen, C 1 -C 4 - alkyl, phenyl, carboxy or halogen a is)], according to claim 1 porous polymer according.
(4)
Q is the following formula:
Embedded image
The porous polymer according to any one of claims 1 to 3 , which is a radical represented by the following formula:
(5)
X is, -O -, - NH- or -N (C 1 -C 2 - alkyl) - can be a porous polymer according to any one of claims 1-4.
6.
A is of the formula (4) wherein R 2 is hydrogen or fluorine, z is 0, a is 1-4, b is 0-4, and c is The porous polymer according to any one of claims 1 to 5 , which is a radical of 1 to 10).
7.
A is the formula (4a):
-(CH 2 ) a- (CF 2 ) c -R 2 (4a)
A radical represented in, R 2 is hydrogen or fluorine, a is an integer of 1 or 2, and c is an integer of 1 to 10, any one of claims 1 to 6 A porous polymer as described.
Claim 8.
When the polymerizable component is represented by the formula (1) [where Q is the following formula:
Embedded image
Wherein X is —O—, —NH— or —N (C 1 -C 2 -alkyl) —, and A is of the formula (4a):
-(CH 2 ) a- (CF 2 ) c -R 2 (4a)
Wherein R 2 is hydrogen or fluorine; a is an integer of 1 or 2; and c is an integer of 1 to 10). Item 4. The porous polymer according to Item 1.
9.
The porous polymer according to any one of claims 1 to 8 , wherein the polymerizable component comprises one or more different monomers of the formula (1).
10.
The porous polymer according to any one of claims 1 to 8 , wherein the polymerizable component comprises one or more different monomers of the formula (1) and a crosslinking agent.
11.
The crosslinking agent is mono-, di-, tri- or tetraethylene glycol diacrylate or dimethacrylate or formula (6):
H 2 C = CR 8 -C ( O) O-H 2 C- (CF 2) 1-10 -CH 2 -O (O) C-CR 8 = CH 2 (6)
The porous polymer according to claim 10 , which is a fluorinated compound represented by the formula: wherein R 8 is hydrogen or methyl.
12.
The porosity according to any one of claims 1 to 8 , wherein the polymerizable component comprises one or two or more different monomers of the formula (1), one or two or more different hydrophilic comonomers, and a crosslinking agent. Polymer.
Claim 13
a) a step of forming a mixture comprising a polymerizable component and an organic solvent, wherein the polymerizable component is a free- radical polymerizable unsaturated monomer of the formula (1) according to claim 1; Comonomer and / or crosslinking agent);
b) polymerizing the mixture, wherein, immediately after the polymerization of the mixture, at least a substantial proportion of the organic solvent is in the form of a discrete phase, and the discrete organic solvent phase is interpenetrated throughout the mixture Forming a network or dispersed throughout the mixture); and c) removing the discrete organic solvent phase.
14.
Organic solvent, C 2 -C 8 - an alcohol, The method of claim 13.
15.
A molded article comprising the porous polymer according to any one of claims 1 to 12 .
16.
16. The molded article according to claim 15 , which is a biomedical device, especially an ophthalmic device.
17.
The molded article according to claim 15 , which is a medical implant.
18.
The molded article according to claim 15 , which is an ophthalmic prosthesis, in particular a corneal implant.
(19)
The molded article according to claim 15 , which is a wound healing dressing.
20.
Use of a non-porous or porous polymer obtained by polymerizing the polymerizable component according to claim 1 as a cell growth material.
21.
Use of a non-porous or porous polymer obtained by polymerizing the polymerizable component of claim 1 as a cell growth supporting coating for biomedical or biomaterial devices or applications.
22.
Use of a non-porous or porous polymer obtained by polymerizing the polymerizable component according to claim 1 for the manufacture of an implantable intraocular lens or artificial cornea.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99103165.9 | 1999-02-18 | ||
EP99103165 | 1999-02-18 | ||
PCT/EP2000/001267 WO2000049058A1 (en) | 1999-02-18 | 2000-02-16 | New biomaterials |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002537422A JP2002537422A (en) | 2002-11-05 |
JP2002537422A5 true JP2002537422A5 (en) | 2007-04-05 |
Family
ID=8237576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000599794A Pending JP2002537422A (en) | 1999-02-18 | 2000-02-16 | New biomaterial |
Country Status (7)
Country | Link |
---|---|
US (1) | US6503958B2 (en) |
EP (1) | EP1159317B1 (en) |
JP (1) | JP2002537422A (en) |
AT (1) | ATE288932T1 (en) |
AU (1) | AU3155700A (en) |
DE (1) | DE60018044T2 (en) |
WO (1) | WO2000049058A1 (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5976000A (en) * | 1999-06-22 | 2001-01-09 | Novartis Ag | Process for the manufacture of moldings |
US6255360B1 (en) | 2000-05-15 | 2001-07-03 | Novartis Ag | Process for the manufacture of moldings |
WO2002021965A1 (en) | 2000-09-12 | 2002-03-21 | Anamed, Inc. | System for packaging and handling an implant and method of use |
US8668735B2 (en) | 2000-09-12 | 2014-03-11 | Revision Optics, Inc. | Corneal implant storage and delivery devices |
US6953832B2 (en) * | 2001-01-15 | 2005-10-11 | Ivoclar Vivadent Ag | Dental materials based on polyfunctional amides |
AU2002360251A1 (en) * | 2001-09-28 | 2003-06-23 | Boston Scientific Limited | Medical devices comprising nanocomposites |
EP1499487A1 (en) * | 2002-04-05 | 2005-01-26 | Koninklijke Philips Electronics N.V. | A mould, a method of manufacturing the same as well as its use |
US20090325859A1 (en) * | 2003-09-19 | 2009-12-31 | Northwestern University | Citric acid polymers |
US20050063939A1 (en) | 2003-09-19 | 2005-03-24 | Northwestern University | Novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same |
EP1682161A4 (en) * | 2003-10-29 | 2011-12-07 | Gentis Inc | Polymerizable emulsions for tissue engineering |
US7534495B2 (en) * | 2004-01-29 | 2009-05-19 | Boston Scientific Scimed, Inc. | Lubricious composition |
US8900296B2 (en) | 2007-04-20 | 2014-12-02 | Revision Optics, Inc. | Corneal inlay design and methods of correcting vision |
US8057541B2 (en) | 2006-02-24 | 2011-11-15 | Revision Optics, Inc. | Method of using small diameter intracorneal inlays to treat visual impairment |
US10835371B2 (en) | 2004-04-30 | 2020-11-17 | Rvo 2.0, Inc. | Small diameter corneal inlay methods |
US8535702B2 (en) | 2005-02-01 | 2013-09-17 | Boston Scientific Scimed, Inc. | Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility |
US10555805B2 (en) | 2006-02-24 | 2020-02-11 | Rvo 2.0, Inc. | Anterior corneal shapes and methods of providing the shapes |
CN101528822A (en) * | 2006-07-05 | 2009-09-09 | 新加坡科技研究局 | Porous polymeric articles |
GB0620537D0 (en) * | 2006-10-17 | 2006-11-22 | Univ Southampton | Copolymers suitable for use in corneal bandages |
US8162953B2 (en) | 2007-03-28 | 2012-04-24 | Revision Optics, Inc. | Insertion system for corneal implants |
US9271828B2 (en) | 2007-03-28 | 2016-03-01 | Revision Optics, Inc. | Corneal implant retaining devices and methods of use |
US9549848B2 (en) | 2007-03-28 | 2017-01-24 | Revision Optics, Inc. | Corneal implant inserters and methods of use |
US8378011B2 (en) * | 2007-12-27 | 2013-02-19 | Boston Scientific Scimed, Inc. | Enhanced durability of hydrophilic coatings |
JP2009168875A (en) * | 2008-01-11 | 2009-07-30 | Mo-Wei Hung | Forming method for silicon contact lens and its structure |
US9539143B2 (en) | 2008-04-04 | 2017-01-10 | Revision Optics, Inc. | Methods of correcting vision |
US20100048759A1 (en) * | 2008-08-22 | 2010-02-25 | Ecolab Inc. | Method for lubricating surgical instruments |
US8469948B2 (en) | 2010-08-23 | 2013-06-25 | Revision Optics, Inc. | Methods and devices for forming corneal channels |
CN103797053B (en) | 2011-05-04 | 2017-06-20 | 康奈尔大学 | Segmented copolymer film and its production and use |
WO2013059813A1 (en) | 2011-10-21 | 2013-04-25 | Revision Optics, Inc. | Corneal implant storage and delivery devices |
JP5932501B2 (en) * | 2012-06-06 | 2016-06-08 | キヤノン株式会社 | Curable composition and pattern forming method using the same |
WO2014039495A1 (en) | 2012-09-05 | 2014-03-13 | University Of Miami | Novel keratoprosthesis, and system and method of corneal repair using same |
US9481138B2 (en) * | 2013-03-15 | 2016-11-01 | Johnson & Johnson Vision Care, Inc. | Sealing and encapsulation in energized ophthalmic devices with annular inserts |
US20150037385A1 (en) * | 2013-08-02 | 2015-02-05 | Northwestern University | Ceramic-containing bioactive inks and printing methods for tissue engineering applications |
US20150211967A1 (en) * | 2014-01-29 | 2015-07-30 | Trajan Scientific Australia Pty Ltd | Preparation of samples for analysis and sampling device therefor |
WO2015175880A1 (en) | 2014-05-15 | 2015-11-19 | Northwestern University | Ink compositions for three-dimensional printing and methods of forming objects using the ink compositions |
CZ306792B6 (en) * | 2014-05-21 | 2017-07-12 | Lucie Palasová | A device for manipulating a contact lens in the eye region and the methods of its manufacture |
WO2016085584A2 (en) | 2014-10-15 | 2016-06-02 | Northwestern University | Graphene-based ink compositions for three-dimensional printing applications |
WO2016144404A1 (en) | 2015-03-12 | 2016-09-15 | Revision Optics, Inc. | Methods of correcting vision |
US10793733B2 (en) | 2015-04-07 | 2020-10-06 | Northwestern University | Ink compositions for fabricating objects from regoliths and methods of forming the objects |
US11628409B2 (en) | 2016-04-28 | 2023-04-18 | Terapore Technologies, Inc. | Charged isoporous materials for electrostatic separations |
US10326336B2 (en) | 2016-06-30 | 2019-06-18 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
US10568240B2 (en) | 2016-06-30 | 2020-02-18 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
US10468920B2 (en) | 2016-09-01 | 2019-11-05 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
DE102016012001A1 (en) * | 2016-10-06 | 2018-04-12 | Karlsruher Institut für Technologie | Highly fluorinated nanostructured polymer foams for the production of super-repellent surfaces |
JP7104040B2 (en) | 2016-11-17 | 2022-07-20 | ケー. シースジ,ジェイラジ | Isoporous self-assembling block copolymer film containing a high molecular weight hydrophilic additive and a method for producing the same. |
US20190307610A1 (en) * | 2016-11-28 | 2019-10-10 | Terapore Technologies, Inc. | Wound treating system and methods of using and assembling |
CA3054137C (en) | 2017-02-22 | 2023-02-21 | Terapore Technologies, Inc. | Ligand bound mbp membranes, uses and method of manufacturing |
US10622868B2 (en) | 2017-03-29 | 2020-04-14 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
US10760672B2 (en) | 2017-03-29 | 2020-09-01 | Ford Global Technologies, Llc | Coolant system pressure drop reduction |
US10560002B2 (en) | 2017-03-29 | 2020-02-11 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
CN110621394A (en) | 2017-05-12 | 2019-12-27 | 特拉波雷技术有限公司 | Chemically resistant fluorinated multiblock polymer structures, methods of manufacture and uses |
MX2020009506A (en) | 2018-03-12 | 2021-01-15 | Terapore Tech Inc | Isoporous mesoporous asymmetric block copolymer materials with macrovoids and method of making the same. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5783299A (en) * | 1986-01-21 | 1998-07-21 | Seiko Epson Corporation | Polarizer plate with anti-stain layer |
JPS62193646A (en) * | 1986-02-20 | 1987-08-25 | Mitsubishi Chem Ind Ltd | Separating agent |
DE3844619A1 (en) * | 1988-12-10 | 1990-07-12 | Goldschmidt Ag Th | USE OF PERFLUOROALKYL GROUPS HAVING (METH) ACRYLIC ACID ESTERS IN DENTAL TECHNOLOGY |
US5076844A (en) * | 1988-12-10 | 1991-12-31 | Goldschmidt AG & GDF Gesellschaft fur Dentale Forschung u. Innovationen GmbH | Perfluoroalkyl group-containing (meth-)acrylate esters, their synthesis and use in dental technology |
JP2866697B2 (en) | 1990-02-19 | 1999-03-08 | 臼井国際産業株式会社 | Method of forming tough electrical insulation layer on copper material surface |
ES2141485T3 (en) * | 1995-04-04 | 2000-03-16 | Novartis Ag | USE OF POLYMERS AS A POLYMER SUBSTRATE FOR CELL GROWTH. |
US5783082A (en) * | 1995-11-03 | 1998-07-21 | University Of North Carolina | Cleaning process using carbon dioxide as a solvent and employing molecularly engineered surfactants |
SE9504205D0 (en) * | 1995-11-24 | 1995-11-24 | Pharmacia Biotech Ab | A chromatographic separation method and device |
US7416300B2 (en) * | 2006-05-25 | 2008-08-26 | Coopervision International Holding Company, Lp | Measurement of lenses and lens molds using optical coherence tomography |
-
2000
- 2000-02-16 DE DE60018044T patent/DE60018044T2/en not_active Expired - Lifetime
- 2000-02-16 WO PCT/EP2000/001267 patent/WO2000049058A1/en active IP Right Grant
- 2000-02-16 AU AU31557/00A patent/AU3155700A/en not_active Abandoned
- 2000-02-16 JP JP2000599794A patent/JP2002537422A/en active Pending
- 2000-02-16 EP EP00909189A patent/EP1159317B1/en not_active Expired - Lifetime
- 2000-02-16 AT AT00909189T patent/ATE288932T1/en not_active IP Right Cessation
-
2001
- 2001-08-14 US US09/929,396 patent/US6503958B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002537422A5 (en) | ||
US4452776A (en) | Hydrogel implant article and method | |
US6653420B2 (en) | Porous hydrogels | |
EP0551309B1 (en) | Surface modified surgical instruments, devices, implants and the like | |
US5632773A (en) | Biostable corneal implants | |
US6632887B2 (en) | Coating compositions and methods for reducing edge glare in implantable ophthalmic lenses | |
JP5096793B2 (en) | Polymer composition and ophthalmic lens body | |
US5130160A (en) | Ocular implants and methods for their manufacture | |
GB2190387A (en) | Hydrophilic copolymers for wound dressings and other biomedical uses | |
Refojo et al. | Poly (methyl acrylate‐co‐hydroxyethyl acrylate) hydrogel implant material of strength and softness | |
US20020128346A1 (en) | Hydrogels | |
TW202103651A (en) | Non-degrading swellable polymers as materials for biomedical devices | |
EP0286433B1 (en) | Improved ocular implants and methods for their manufacture | |
JP2011229981A (en) | Covalently-bound, hydrophilic coating composition for surgical implant | |
JP2002511316A5 (en) | ||
JP2000507298A (en) | High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide | |
WO1992005694A1 (en) | Improved ocular implants and methods for their manufacture | |
JP2007537302A (en) | Therapeutic thermosensitive polymers and methods of preparation | |
JP2008509240A (en) | Polymers and methods having continuous pores for drug delivery | |
EP0358195A2 (en) | Solid high polymer substance, process and use thereof | |
CA1157981A (en) | Hydrogel implant article and method | |
CA2381270C (en) | Hydrophobically-bound, hydrophilic coating compositions for surgical implants | |
AU768090B2 (en) | Coating of implantable ophthalmic lenses to reduce edge glare | |
JP2000516520A (en) | Materials used in glaucoma filtration devices | |
KR20190050025A (en) | Tissue Expander for Dental Applications and Method for Fabricating the Same |